Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) read with Regulation 41(2) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, (SEBI ICDR Regulations), Global Health has informed that it enclosed the Monitoring Agency Report, towards utilization of proceeds of Initial Public Offer of the Company for the quarter ended December 31, 2022, issued by CRISIL Ratings.
The above information is a part of company’s filings submitted to BSE.
